Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders

E-ISSN： 2212-3954|10|2|157-177

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.10, Iss.2, 2015-08, pp. : 157-177

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Patents in CNS Drug Discovery: The Management of Inflammation in the Central Nervous System

Recent Patents on CNS Drug Discovery, Vol. 4, Iss. 2, 2009-06 ,pp. : 86-95

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Patents on Novel P2X7 Receptor Antagonists and their Potential for Reducing Central Nervous System Inflammation

Recent Patents on CNS Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 35-45

Bentham Science Publishers

Access to resources Recommend Favorite

Central Nervous System Symptoms of Elderly Subjects Using Antihypertensive Drugs

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 32, Iss. 1, 1984-01 ,pp. : 5-10

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Gastrin-Releasing Peptide Receptor as a Therapeutic Target in Central Nervous System Disorders

Recent Patents on CNS Drug Discovery, Vol. 2, Iss. 2, 2007-06 ,pp. : 125-129

Bentham Science Publishers

Access to resources Recommend Favorite

Management of sexual dysfunction due to central nervous system disorders: a systematic review

BJU INTERNATIONAL, Vol. 115, Iss. S6, 2015-04 ,pp. : 47-56

John Wiley & Sons Inc

Access to resources Recommend Favorite